MEI Pharma, Inc. (MEIP)

MEI Pharma Revenue

MEI Pharma had revenue of $66.75M in the twelve months ending March 31, 2024, with 13.58% growth year-over-year. In the fiscal year ending June 30, 2023, MEI Pharma had annual revenue of $48.82M with 19.95% growth.

• Revenue (ttm): $66.75M
• Revenue Growth: +13.58%
• P/S Ratio: 0.29
• Revenue / Employee: $1,451,174
• Employees: 46
• Market Cap: 19.06M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2023	48.82M	8.12M	19.95%
Jun 30, 2022	40.70M	5.90M	16.96%
Jun 30, 2021	34.80M	7.04M	25.36%
Jun 30, 2020	27.76M	22.84M	464.72%
Jun 30, 2019	4.92M	3.29M	203.02%
Jun 30, 2018	1.62M	-21.63M	-93.02%
Jun 30, 2017	23.25M	-	-
Jun 30, 2016	0	-	-
Jun 30, 2015	0	-	-
Jun 30, 2014	0	-	-
Jun 30, 2013	0	-	-
Jun 30, 2012	0	-	-
Jun 30, 2011	0	-	-
Jun 30, 2010	0	-	-
Jun 30, 2009	0	-	-
Jun 30, 2008	674.00K	29.00K	4.50%
Jun 30, 2007	645.00K	199.00K	44.62%
Jun 30, 2006	446.00K	138.00K	44.81%
Jun 30, 2005	308.00K	115.00K	59.59%
Jun 30, 2004	193.00K	48.00K	33.10%
Jun 30, 2003	145.00K	138.00K	1,971.43%
Jun 30, 2002	7.00K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.